ABSTRACT-We have suggested that cyclopiazonic acid (CPA), a Ca 2+-ATPase inhibitor, produces nitric oxide (NO) by triggering a Ca2+-influx resulting from Ca 2+-depletion in the endoplasmic reticulum of endothelial cells. The tyrosine kinase inhibitor methyl 2,5-dihydroxycinnamate, while having no effect on relaxations induced by A23187 or Na nitroprusside, did inhibit the CPA-induced relaxation and cyclic GMP formation in rat aorta. Tyrosine kinase may participate in endothelial NO synthesis through activation of a Ca 2' entry mechanism.
Endothelial cells respond to chemical or physical stimuli with the release of nitric oxide (NO) to induce vascular smooth muscle relaxation. The endothelial NO synthase activity is dependent on cytoplasmic Ca 21 that has been suggested to be mostly derived from the extracellular space (1, 2) . Recent studies suggested that depletion of the Ca2+ store or endoplasmic reticulum (ER) could send an unidentified signal to the plasma membrane and allow the Ca 2+ to enter the cell in many types of non-excitable cells (3, 4) , including the endothelial cells in culture (5) . This hypothesis has been developed by the use of specific inhibitors of the ER Ca 2+-ATPase, such as cyclopiazonic acid (CPA, ref. 6 ) and thapsigargin, that could empty the Ca 21 in the ER without any known interaction with receptor-mediated cell signaling (3). More recently, the model has been shown to be applicable to intact endothelial cells and to have an important functional significance: the Ca 2+-ATPase inhibitors induced an endothelial NOmediated vasorelaxation that was exclusively dependent on the extracellular Ca 21 (2) . In this study, we investigated the CPA-induced relaxation and cyclic GMP formation in the rat aorta to obtain a clue to delineate the Ca 2+ entry mechanism in endothelial cells, with a special reference to tyrosine kinase that has been recently shown to be intimately involved in a diversity of cellular functions (7), including cellular Ca2+-handling (8) . Some results of this work have been communicated at the 67th Annual Meeting of The Japanese Pharmacological Society, 1994 (9) .
The thoracic aorta was dissected from male Wistar rat (8-to 12-weeks-old, 250-350g in body weight). The 3-mm-long ring preparations were cut and set up in organ baths containing physiological saline solution of the following composition: 115.3 mM NaCI, 4.7 mM KCI, 2.5 mM CaC12, 1.2 mM MgSO4, 1.2 mM KH2PO4, 25.0 mM NaHCO3 and 11.1 mM glucose. The solution was kept at 34V and continuously aerated with 5% CO2 in oxygen. The mechanical response was measured isometrically under a resting tension of 1.0 g. Endothelial integrity was confirmed by testing the relaxation induced by acetylcholine (ACh). The concentration-relaxation curve for CPA, A23187 or sodium nitroprusside was constructed by cumulative application of each drug in the aortic rings precontracted with phenylephrine at 1 tM, corresponding to the 80% effective concentration (EC80). In most studies, control curves and those obtained in the presence of methyl 2,5-dihydroxycinnamate, which was applied 20 min before the addition of phenylephrine, were determined on the same aortic rings, except for the experiments with A23187. The Ca 21 ionophore was applied once to each ring in the absence or presence of methyl 2,5-dihydroxycinnamate since the effect of the relaxant was irreversible in nature. Cyclic GMP contents in tissues were determined by radioimmunoassay using a commercially available kit, as described previously (2) .
Data are expressed as means±S.E. with the number of observations in parentheses. Difference between values was considered to be significant when the P value was less than 0.05 by Student's t-test or Duncan's new multiple range test.
The following drugs were used: ACh (Daiichi Phar- Figure 1A shows that methyl 2,5-dihydroxycinnamate inhibited the CPA-induced relaxation noncompetitively in a concentration-dependent manner. The values of -log EC50 of CPA in the absence (control) and presence of 10 and 30 pM methyl 2,5 -dihydroxycinnamate were 5.99±0.09 (n=5), 5.77--'-0.16 (n=5) and 5.82±0.14 (n=5), respectively, and the maximum relaxation of the control and 10 and 30 pM methyl 2, 5-dihydroxycinnamate-treated tissues were 95.7--+-1.8% (n=5), 64.7±10.4% (n=5) and 37.1±
10.9% (n=5) of the precontraction, respectively. In contrast, methyl 2, 5-dihydroxycinnamate (30 pM) had no effect on the relaxation induced by sodium nitroprusside or A23187 (Fig. 1B) .
The tissue cyclic GMP content was increased in response to CPA (10 pM) from the basal value of 0.87 ± 0.12 pmol/mg protein (n=5) to 49.5--+-8.4
pmol/mg protein (n = 5). Methyl 2,5 -dihydroxycinnamate (30 pM) significantly reduced the stimulated cyclic GMP formation to 15.8 ± 3.1 pmol/mg protein (n=5) (P <0.01), without any effect on the basal cyclic GMP content [0.87 ± 0.12 pmol/mg protein (n = 5) and 1.20 ± 0.20 pmol/mg protein (n=4) in the absence and presence of 30 pM methyl 2, 5-dihydroxycinnamate, respectively (P>0.05)]. Although A23187 (0.1 pM) and sodium nitroprusside (0.1 pM) also increased the cyclic GMP content to 20.6 ± 2.4 (n = 4) and 22.9 ± 3.6 pmol/mg protein (n=5), respectively, methyl 2,5-dihydroxycinnamate (30 pM) had no significant effect on the stimulated production of cyclic GMP [A23187: 18.9 ± 4.2 pmol/mg protein (n = 4); sodium nitroprusside: 19.5 ± 2.3 pmol/mg protein (n=5)] (Fig. 2) .
The present results are the first to show that the CPAinduced vasorelaxation, accompanied by increased cyclic GMP formation, was inhibited by methyl 2,5-dihydroxycinnamate, which has been reported to be a tyrosine kinase inhibitor (10) . In rat thoracic aorta, it has been previously assumed by us (2) that CPA may act on the ER in endothelial cells to deplete Ca 2+ by inhibition of the Ca 2+-pumping ATPase, which then triggers the influx of extracellular Ca 21 in a similar way to that proposed in the capacitative Ca 2+ entry model for parotid acinar cells (3) and cultured endothelial cells (5) . Methyl 2,5-dihydroxycinnamate had no effect on the relaxation or cyclic GMP formation induced by sodium nitroprusside, suggesting that the impaired responses to CPA did not result from an inability of the smooth muscle to respond to NO but reflected a reduced release of the mediator from the endothelial cells. Furthermore, since there was no change in the responses to the Ca 21 ionophore A23187, methyl 2,5-dihydroxycinnamate would not attenuate the CPA-induced relaxation or cyclic GMP formation as a result of inhibition of Ca 2+/calmodulin-dependent activation of NO synthase. Similar results were obtained with another type of tyrosine kinase inhibitor herbimycin A (? 3 1M, our unpublished observation). In the light of the capacitative Ca 2+ entry model, methyl 2,5-dihydroxycinnamate is likely to interfere with a process that links depletion of Ca 21 in the ER with extracellular Ca 2+ entry or that controls the activity of plasmalemmal Ca 2+ channels. It is, however, possible that the drug may have an effect on the function of the ER, such as the regulation of the Ca 2+-ATPase activity or more plausibly, a sensor mechanism to monitor the content of Ca 2+ in the ER. The mode of action of tyrosine kinase inhibitors in endothelial cells may have some resemblance to those in other non-excitable cells, as revealed mainly by measurement of the intracellular Ca 2+ concentrations with a dye (8) . Methyl 2,5-dihydroxycinnamate failed to decrease the cyclic GMP content in the basal state, where the Ca 2+ in the ER was supposed to be loaded. This result seems to be compatible with the capacitative Ca 2+ entry model, in that the Ca 2+ entry pathway, which was sensitive to methyl 2, 5-dihydroxycinnamate, could not be utilized unless the Ca 2+ in the ER was depleted.
In conclusion, the present data lead us to suggest that a tyrosine kinase would participate in the CPA-induced, endothelium-dependent relaxation, possibly through activation of a Ca 2+ entry mechanism for NO production in rat aortic endothelial cells, and furthermore suggests that the tyrosine kinase-dependent Ca 2+ entry may actually have a significance in cellular function.
